Plenary Speaker: David A. DeGoey, PhD

Research Fellow @ AbbVie 

Mining AbbVie's Global ADME Database for New Insights into Oral Absorption of bRo5 Drugs

Plenary Speaker: Jean-Claude Marshall, PhD

Head of Clinical Biomarkers @ Moderna

Biomarker challenges for assay development for COVID19 vaccines and therapeutics - title TBA

Plenary Speaker: Professor Sheldon H. Preskorn, MD

Department of Psychiatry and Behavioral Sciences, Wichita School of Medicine

Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions and What Can Be Done to Minimize the Adverse Outocomes

Professor Jan Kihlberg,PhD

Organic Chemistry, Uppsala University, Sweden

Molecular Chameleonicity and Cell Permeability of Drugs and PROTACs in the bRo5 Space

Matthias Wittwer,PhD

PDM Project Leader @ Roche

Optimizing Proteolysis - Targeting PROTAC for Oral Drug Delivery: A Drug Metabolism and PK Perspective

Danielle Swaney, PhD

Assistant Adjunct Professor @ UCSF

Discovery of SARS-CoV-2 Host-protein Targets for Antiviral Drug Repurposing

Tao Jiang, PhD

Senior Scientist @ Moderna

Title TBA - COVID19

 Manjinder Lall, PhD 

Senior Principal Scientist @ Pfizer

P450 lead diversification/COVID19 - Talk Title TBA

Photini Pitsikas, PhD

Principal Scientist @ Charles River Laboratories

Ultra-Sensitive Methods as a Means to Establish Levels for Key Biomarkers

 Noah Post, PhD

Assistant Director @ Ionis Pharmaceuticals

Bioanalysis of Therapeutic Oligonucleotides Using LC-MS and ELISA

Edward Price, PhD

Senior Scientist I @ AbbVie

A Global Analysis of Models for Predicting Human Absorption: QSAR, In Vitro, and Pre-clinical Models

Fabio Broccatelli, PhD

Senior Scientist @ Genentech

Tissue Binding in Predictive Modeling and Drug Design

Alexander Kozhich, PhD

Director @ Bristol Myers Squibb

Cell Therapy - Title TBA 

Vaishali Dixit, PhD

Director, DMPK/Preclinical Development @ Kymera Therapeutics

"Can We Predict the Vss and Tissue Distribution of Targeted Protein Degraders Using Mechanistic PBPK Models?"

Andrew Melton, PhD

Associate Director @ BioMarin Pharmaceutical

ddPCR work assay development and validation for gene therapies/linkage analysis and multiplexing - Title TBA

Jennifer Zimmer, PhD

Laboratory Director @ Alturas Analytics

Bioanalytical Challenges: Developing a rugged chiral assay for the biomarker 2-hydroxyglutaric acid for use in routine clinical analysis of plasma samples from oncology studies

Julie Seroogy, PhD

Senior Director, Clinical Pharmacokinetics, MyoKardia/BMS

Bioanalytical Approaches to Support Individualized Dosing in Global Clinical Studies 

 Dr. Brahim Achour

Research Fellow, Centre for Applied Pharmacokinetics Research (CAPKR), University of Manchester

Title TBA - Liquid Biopsy

Li Di, PhD

Research Fellow @ Pfizer

What is HLM-HHEP Disconnect Telling Us?

Abbas Bandukwala, MS

Science Policy Analyst, Office of New Drugs/CDER, U.S. Food and Drug Administration

Analytical Considerations for Biomarker Development and Qualification

Kevin Bateman, PhD

Scientific Associate Vice President @ Merck

Lab of the Future 

Diane Ramsden, PhD

Associate Scientific Director Global DMPK @ Takeda

Developing Oligonucleotide Therapeutics, Considerations for DMPK Scientists

Don Zhong, PhD

Director BioAnalytical Sciences, Sangamo Therapeutics, Inc.

Title TBA

 &

Joint lecture:

Allison McMullen, PhD (ABMM)

Scientific Affairs Manager @ Roche Diagnostics

Allyson Kozak, PhD, MBA, NRCC

Scientific Affairs Manager @ Roche